A U.S. study found that hypertensive patients with a common subtype of the NPPA gene are more likely to respond better to a calcium channel blocker than to a diuretic. The finding indicates that genetic makeup may affect a patient's reaction to hypertension drugs and may eventually assist doctors in finding the right treatment for an individual, the researchers said.

Related Summaries